Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera S Egorova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
White-to-Beige and Back: Adipocyte Conversion and Transcriptional ReprogrammingStanislav Boychenko, Vera S Egorova, Andrew Brovin, et al.
Pharmaceutics|May 25, 2024
Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer ProgressionAlyona B Kuznetsova, Ekaterina P Kolesova, Alessandro Parodi, et al.
Pharmaceutics|July 29, 2023
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer TreatmentVera S Egorova, Ekaterina P Kolesova, Manu Lopus, et al.
International Journal of Molecular Sciences|September 13, 2025
Inorganic Silica Nanoparticles Increase Lysosomal Biology and Protease ActivityAnastasiia O Syrocheva, Valentina I Gorbacheva, Vera S Egorova, et al.
Cancers|August 14, 2025
Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease ManagementStepan A Kopytov, Guzel R Sagitova, Dmitry Y Guschin, et al.
Heliyon|May 28, 2024
Physiologically based pharmacokinetic model for predicting the biodistribution of albumin nanoparticles after induction and recovery from acute lung injuryElena O Kutumova, Ilya R Akberdin, Vera S Egorova, et al.
International Journal of Molecular Sciences|October 27, 2022
Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis ToolsElena O Kutumova, Ilya R Akberdin, Ilya N Kiselev, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinicsVera S Egorova, Ekaterina P Kolesova, Maya V Voronina, et al.
International Journal of Molecular Sciences|June 28, 2023
Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G ExpressionEkaterina P Kolesova, Vera S Egorova, Anastasiia O Syrocheva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
White-to-Beige and Back: Adipocyte Conversion and Transcriptional ReprogrammingStanislav Boychenko, Vera S Egorova, Andrew Brovin, et al.
Pharmaceutics|May 25, 2024
Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer ProgressionAlyona B Kuznetsova, Ekaterina P Kolesova, Alessandro Parodi, et al.
Pharmaceutics|July 29, 2023
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer TreatmentVera S Egorova, Ekaterina P Kolesova, Manu Lopus, et al.
International Journal of Molecular Sciences|September 13, 2025
Inorganic Silica Nanoparticles Increase Lysosomal Biology and Protease ActivityAnastasiia O Syrocheva, Valentina I Gorbacheva, Vera S Egorova, et al.
Cancers|August 14, 2025
Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease ManagementStepan A Kopytov, Guzel R Sagitova, Dmitry Y Guschin, et al.
Heliyon|May 28, 2024
Physiologically based pharmacokinetic model for predicting the biodistribution of albumin nanoparticles after induction and recovery from acute lung injuryElena O Kutumova, Ilya R Akberdin, Vera S Egorova, et al.
International Journal of Molecular Sciences|October 27, 2022
Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis ToolsElena O Kutumova, Ilya R Akberdin, Ilya N Kiselev, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinicsVera S Egorova, Ekaterina P Kolesova, Maya V Voronina, et al.
International Journal of Molecular Sciences|June 28, 2023
Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G ExpressionEkaterina P Kolesova, Vera S Egorova, Anastasiia O Syrocheva, et al.
Pageof 1